Abstract
A human trial was carried out to assess the ileal and fecal survival of Lactobacillus casei DN-114 001 ingested in fermented milk. Survival rates were up to 51.2% in the ileum and 28.4% in the feces. The probiotic bacterium has the capacity to survive during its transit through the human gut.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Animals
-
Colony Count, Microbial
-
Diet*
-
Feces / microbiology
-
Female
-
Fermentation*
-
Gastrointestinal Tract / microbiology*
-
Humans
-
Ileum / microbiology
-
Lacticaseibacillus casei / growth & development*
-
Lacticaseibacillus casei / isolation & purification
-
Male
-
Milk / metabolism*
-
Milk / microbiology
-
Probiotics*
-
Treatment Outcome